166 related articles for article (PubMed ID: 15358619)
21. Intermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomes.
Neumann D; Wikström L; Watowich SS; Lodish HF
J Biol Chem; 1993 Jun; 268(18):13639-49. PubMed ID: 8514796
[TBL] [Abstract][Full Text] [Related]
22. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
[TBL] [Abstract][Full Text] [Related]
23. Amino acid residues 268-276 of the erythropoietin receptor contain an endocytosis motif and are required for erythropoietin-mediated proliferation.
Flint-Ashtamker G; Eisen-Lev R; Cohen J; Jun-shen Huang L; Neumann D
FEBS Lett; 2002 May; 518(1-3):189-94. PubMed ID: 11997044
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitination regulates the internalization, endolysosomal sorting, and signaling of the erythropoietin receptor.
Bulut GB; Sulahian R; Ma Y; Chi NW; Huang LJ
J Biol Chem; 2011 Feb; 286(8):6449-57. PubMed ID: 21183685
[TBL] [Abstract][Full Text] [Related]
25. The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation.
Sawyer ST; Hankins WD
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6849-53. PubMed ID: 8341708
[TBL] [Abstract][Full Text] [Related]
26. Activation of the erythropoietin receptor in human skeletal muscle.
Rundqvist H; Rullman E; Sundberg CJ; Fischer H; Eisleitner K; Ståhlberg M; Sundblad P; Jansson E; Gustafsson T
Eur J Endocrinol; 2009 Sep; 161(3):427-34. PubMed ID: 19515792
[TBL] [Abstract][Full Text] [Related]
27. Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia.
Sulahian R; Cleaver O; Huang LJ
Blood; 2009 May; 113(21):5287-97. PubMed ID: 19336760
[TBL] [Abstract][Full Text] [Related]
28. Erythropoietin receptors associate with a ubiquitin ligase, p33RUL, and require its activity for erythropoietin-induced proliferation.
Friedman AD; Nimbalkar D; Quelle FW
J Biol Chem; 2003 Jul; 278(29):26851-61. PubMed ID: 12746455
[TBL] [Abstract][Full Text] [Related]
29. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
Shi J; Yuan B; Hu W; Lodish H
Exp Hematol; 2016 Nov; 44(11):1044-1058.e5. PubMed ID: 27473563
[TBL] [Abstract][Full Text] [Related]
30. Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
Rainville N; Jachimowicz E; Wojchowski DM
Expert Opin Ther Targets; 2016; 20(3):287-301. PubMed ID: 26419263
[TBL] [Abstract][Full Text] [Related]
31. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
Um M; Gross AW; Lodish HF
Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the WSAWSE and cytosolic domains of the erythropoietin receptor affect signal transduction and ligand binding and internalization.
Quelle DE; Quelle FW; Wojchowski DM
Mol Cell Biol; 1992 Oct; 12(10):4553-61. PubMed ID: 1406645
[TBL] [Abstract][Full Text] [Related]
33. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model.
Ruscher K; Freyer D; Karsch M; Isaev N; Megow D; Sawitzki B; Priller J; Dirnagl U; Meisel A
J Neurosci; 2002 Dec; 22(23):10291-301. PubMed ID: 12451129
[TBL] [Abstract][Full Text] [Related]
34. Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms.
Neumann D; Yuk MH; Lodish HF; Lederkremer GZ
Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):391-9. PubMed ID: 8573070
[TBL] [Abstract][Full Text] [Related]
35. JAK kinases control IL-5 receptor ubiquitination, degradation, and internalization.
Martinez-Moczygemba M; Huston DP; Lei JT
J Leukoc Biol; 2007 Apr; 81(4):1137-48. PubMed ID: 17227823
[TBL] [Abstract][Full Text] [Related]
36. Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells.
Fukumoto T; Kubota Y; Kitanaka A; Yamaoka G; Ohara-Waki F; Imataki O; Ohnishi H; Ishida T; Tanaka T
Cell Signal; 2009 Dec; 21(12):1775-83. PubMed ID: 19665053
[TBL] [Abstract][Full Text] [Related]
37. Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment.
Xie Z; Chen F; Wu X; Zhuang C; Zhu J; Wang J; Ji H; Wang Y; Hua X
Curr Eye Res; 2012 Feb; 37(2):138-44. PubMed ID: 22251399
[TBL] [Abstract][Full Text] [Related]
38. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
Bose C; Udupa KB
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C394-405. PubMed ID: 18550701
[TBL] [Abstract][Full Text] [Related]
39. The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells--signals emanating from the erythropoietin receptor.
Klingmüller U
Eur J Biochem; 1997 Nov; 249(3):637-47. PubMed ID: 9395308
[TBL] [Abstract][Full Text] [Related]
40. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface.
Migliaccio AR; Migliaccio G; D'Andrea A; Baiocchi M; Crotta S; Nicolis S; Ottolenghi S; Adamson JW
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11086-90. PubMed ID: 1722318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
